Biochemical approach to new medications

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Immunosuppression

Background:

• The development of antimetabolite drugs has been crucial in treating various diseases.
• Early research focused on purine analogs for their potential therapeutic effects.

Purpose of the Study:

• To provide a historical overview of the discovery and application of key antimetabolite drugs.
• To highlight the evolution of drug development from anticancer agents to immunosuppressants and antibacterials.

Main Methods:

• Historical review of drug discovery and development processes.
• Description of chemical modifications leading to new drug candidates.
• Clinical observations and outcomes associated with drug usage.

Main Results:

• 2,6-diaminopurine evolved into 6-mercaptopurine, an effective treatment for tumors and leukemia.
• 6-mercaptopurine derivatives and azathioprine emerged as vital immunosuppressants for kidney transplant recipients.
• Specific diaminopurines demonstrated selective antifolate activity against bacteria, particularly when combined with sulfanilamide.

Conclusions:

• The journey from 2,6-diaminopurine to azathioprine showcases significant advancements in medicinal chemistry and pharmacology.
• Antimetabolite drug development has yielded life-saving treatments for cancer, organ transplantation, and bacterial infections.
• The synergistic combination of diaminopurines and sulfanilamide represents a highly effective antibacterial strategy.